# OnCo record paper-cemiplimab-bcc-stratigos-lancet-oncol-2021 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-cemiplimab-bcc-stratigos-lancet-oncol-2021/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-cemiplimab-bcc-stratigos-lancet-oncol-2021" ;
  schema:name "Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy"@en ;
  schema:description "In patients whose locally advanced basal cell carcinoma had progressed on or could not tolerate a hedgehog inhibitor, cemiplimab shrank tumours in about three in ten, giving a second-line option where none existed."@en ;
  schema:url <https://onco.cc/key-papers/paper-cemiplimab-bcc-stratigos-lancet-oncol-2021/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S1470-2045(21)00126-1>, <https://pubmed.ncbi.nlm.nih.gov/34000246/> ;
  schema:sameAs <https://doi.org/10.1016/S1470-2045(21)00126-1> ;
  schema:datePublished "2021"^^xsd:gYear ;
  schema:author "Stratigos AJ, Sekulic A, Peris K, et al." ;
  onco:cancers <https://onco.cc/cancers/locally-advanced-bcc/> ;
  onco:drugs <https://onco.cc/drugs/cemiplimab/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .